EPO and chronic kidney disease: A higher estimated EC50 in CKD rats(1360 mIU/mL,RSE 69.9%) than in CIA rats (126 mIU/mL, RSE 31.2%) indicated thatthe impaired EPO responsiveness predominantly contributes to the reducedinduction of ERFE following rHuEPO administration in CKD rats.